Patent directory · USPTO A61K / A61P
Patents matching “Alnylam Pharmaceuticals, Inc.”
376 pharma patents match "Alnylam Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 376 pharmaceutical patents matching "Alnylam Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12031133
GNAQ targeted dsRNA compositions and methods for inhibiting expression
granted -
US 12018260
Tunable Reversir™ compounds
granted -
US 12005074
Extrahepatic delivery
granted -
US 11987792
Compositions and methods for inhibiting expression of the LECT2 gene
granted -
US 11965166
Complement factor B (CFB) iRNA compositions and methods of use thereof
granted -
US 11959081
Transthyretin (TTR) iRNA compositions and methods of use thereof
granted -
US 11944687
Carbohydrate conjugate RNA agents and process for their preparation
granted -
US 11926832
Ketohexokinase (KHK) iRNA compositions and methods of use thereof
granted -
US 11884919
Lipid formulated compositions and methods for inhibiting expression of serum amyloid a gene
granted -
US 11873491
Complement component C5 iRNA compositions and methods of use thereof
granted -
US 11866701
Complement component C3 iRNA compositions and methods of use thereof
granted -
US 11866709
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
granted -
US 11866710
Transmembrane protease, serine 6 (TMPRSS6) iRNA compositions and methods of use thereof
granted -
US 11859185
Glucokinase (GCK) iRNA compositions and methods of use thereof
granted -
US 11840692
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
granted -
US 11834662
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
granted -
US 11827883
Dosages and methods for delivering lipid formulated nucleic acid molecules
granted -
US 11806360
Compositions and methods for treating transthyretin (TTR) mediated amyloidosis
granted -
US 11725209
TMPRSS6 iRNA compositions and methods of use thereof
granted -
US 11725207
Serpina1 iRNA compositions and methods of use thereof
granted -
US 11685918
Programmed cell death 1 ligand 1 (PD-L1) iRNA compositions and methods of use thereof
granted -
US 11679158
Biodegradable lipids for the delivery of active agents
granted -
US 11666653
Carbohydrate conjugates as delivery agents for oligonucleotides
granted -
US 11649459
Superoxide dismutase 1 (SOD1) iRNA compositions and methods of use thereof for treating or preventing superoxide dismutase 1-(SOD1-) associated neurodegenerative diseases
granted